INVIRAGEN, INC.

Organization

FORT COLLINS, CO, US

Business Address
1613 PROSPECT PARKWAY SUITE 100 FORT COLLINS CO 80525 970-672-4918
Mailing Address
1613 PROSPECT PARKWAY SUITE 100 FORT COLLINS CO 80525
State Location
CO
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for live attenuated viruses
- Patent number 8,084,039
- Issue date Dec 27, 2011
- Inviragen, Inc.
- Dan T. Stinchcomb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR DENGUE VIRUS CHIMERIC CONSTRUCTS IN VA...
- Publication number 20140302088
- Publication date Oct 9, 2014
- The Government of the United States of America as Represented by the Secretar
- Daniel T. Stinchcomb
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS
- Publication number 20140271715
- Publication date Sep 18, 2014
- INVIRAGEN, INC.
- Daniel T. Stinchcomb
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS, METHODS AND USES FOR DENGUE VIRUS SEROTYPE-4 CONSTRUCTS
- Publication number 20140134205
- Publication date May 15, 2014
- The Government of the United States of America as Represented by the Secretar...
- Jill A. Livengood
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS, METHODS AND USES FOR EXPRESSION OF ENTEROBACTERIUM-AS...
- Publication number 20130034583
- Publication date Feb 7, 2013
- INVIRAGEN, INC.
- Dan T. Stinchcomb
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

NIH Research Projectlast 12 months

processing...

Count: 21

Research Projects

Information Research Project
Clinical Development of Combination Plague/Smallpox Vaccine
- Application id 8126364
- Award notice date Aug 5, 2011
Information Research Project
Second Generation Dengue Vaccine
- Application id 7921691
- Award notice date Sep 3, 2010
Information Research Project
Clinical Development of Combination Plague/Smallpox Vaccine
- Application id 7932168
- Award notice date Aug 9, 2010
Information Research Project
Preclinical development of a chimeric tetravalent dengue vaccine
- Application id 7681592
- Award notice date Sep 23, 2009
Information Research Project
Clinical Development of Combination Plague/Smallpox Vaccine
- Application id 7747046
- Award notice date Sep 15, 2009
Information Research Project
Development of a Novel, Chimeric Chikungunya Vaccine
- Application id 7681314
- Award notice date Sep 3, 2009
Information Research Project
Second Generation Dengue Vaccine
- Application id 7747001
- Award notice date Aug 28, 2009
Information Research Project
Development of a Novel, Chimeric Chikungunya Vaccine
- Application id 7846691
- Award notice date Jun 4, 2009
Information Research Project
Multivalent HPV Capsomere Vaccines
- Application id 7611911
- Award notice date Sep 26, 2008
Information Research Project
Development of a Novel, Chimeric Chikungunya Vaccine
- Application id 7538312
- Award notice date Sep 1, 2008
Information Research Project
Preclinical development of a chimeric tetravalent dengue vaccine
- Application id 7491487
- Award notice date Aug 31, 2008
Information Research Project
MVA-based vaccines against highly pathogenic avian influenza
- Application id 7416626
- Award notice date Apr 21, 2008
Information Research Project
Preclinical development of a chimeric tetravalent dengue vaccine
- Application id 7291529
- Award notice date Aug 30, 2007
Information Research Project
MVA-based vaccines against highly pathogenic avian influenza
- Application id 7277467
- Award notice date May 3, 2007
Information Research Project
Mucosal modified vaccinina Ankara-based plaque vaccines
- Application id 7197322
- Award notice date Mar 30, 2007
Information Research Project
Preclinical development of a chimeric tetravalent dengue vaccine
- Application id 7134891
- Award notice date Sep 26, 2006
Information Research Project
Mucosal modified vaccinina Ankara-based plaque vaccines
- Application id 7052479
- Award notice date Mar 9, 2006
Information Research Project
Development of Technologies to Facilitate the Use of and Response t...
- Application id 8519184
Information Research Project
Development of Technologies to Facilitate the Use of and Response t...
- Application id 8164633
Information Research Project
Development of Technologies to Facilitate the Use of and Response t...
- Application id 8317498
Information Research Project
Development of Technologies to Facilitate the Use of and Response t...
- Application id 8655498

INVIRAGEN, INC.

Organization

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Methods and compositions for live attenuated viruses

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR DENGUE VIRUS CHIMERIC CONSTRUCTS IN VA...

COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS

COMPOSITIONS, METHODS AND USES FOR DENGUE VIRUS SEROTYPE-4 CONSTRUCTS

COMPOSITIONS, METHODS AND USES FOR EXPRESSION OF ENTEROBACTERIUM-AS...

NIH Research Projectlast 12 months

Research Projects

Clinical Development of Combination Plague/Smallpox Vaccine

Second Generation Dengue Vaccine

Clinical Development of Combination Plague/Smallpox Vaccine

Preclinical development of a chimeric tetravalent dengue vaccine

Clinical Development of Combination Plague/Smallpox Vaccine

Development of a Novel, Chimeric Chikungunya Vaccine

Second Generation Dengue Vaccine

Development of a Novel, Chimeric Chikungunya Vaccine

Multivalent HPV Capsomere Vaccines

Development of a Novel, Chimeric Chikungunya Vaccine

Preclinical development of a chimeric tetravalent dengue vaccine

MVA-based vaccines against highly pathogenic avian influenza

Preclinical development of a chimeric tetravalent dengue vaccine

MVA-based vaccines against highly pathogenic avian influenza

Mucosal modified vaccinina Ankara-based plaque vaccines

Preclinical development of a chimeric tetravalent dengue vaccine

Mucosal modified vaccinina Ankara-based plaque vaccines

Development of Technologies to Facilitate the Use of and Response t...

Development of Technologies to Facilitate the Use of and Response t...

Development of Technologies to Facilitate the Use of and Response t...

Development of Technologies to Facilitate the Use of and Response t...